As biotech turns 20...
Biotechnology applied to pharmaceuticals has made significant contributions to medicine during the past 20 years. Although important products will continue to emerge, benefiting patients and perhaps lowering medical costs, there are too many biopharmaceutical companies chasing too few products, which are themselves over-regulated and incredibly expensive to test and bring to market.
Miller
Henry I
HI
Hoover Institution, Stanford University, Stanford, California 94305-6010, USA. miller@hoover.stanford.edu
D001709:Biotechnology / Q000191:economics / Q000331:legislation & jurisprudence / Q000639:trends*; D016527:Drug Costs / Q000639:trends*; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence / Q000639:trends*; D006801:Humans